Chemotherapy in Ewing's sarcoma: The Scandinavian Sarcoma Group experience

Acta Orthopaedica Scandinavica, Supplement

Volumn 70, Issue 285, 1999, Pages 69-73

  Elomaa, Inkeri ^a,e   Blomqvist, Carl ^a   Saeter, Gunnar ^b   Nilbert, Mef ^d   Monge, Odd R ^c   Wiebe, Thomas ^d   Alvegård, Thor A ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; BONE TUMOR; CANCER STAGING; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REGISTER; SCANDINAVIA; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SARCOMA, EWING'S; SCANDINAVIA;

EID: 0032769533     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alvegård T A, Solheim O, Åkerman M, Berg N O. Ewing's sarcoma. A preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989; 28(Suppl.2): 59-64.
2. Bacci G, Picci P, Gerlinzoni F et al. Localized Ewing's sarcoma of bone: ten years experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapy. Eur J Cancer Clin Oncol 1985; 21: 165-75.
3. Bacci G, Toni A, Avella M et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989; 63: 1477-86.
4. Bone F, Le Chevalier T, Spielman M et al. Drug chemotherapy of Ewing's sarcoma. ECCO 4, Madrid 1987, p. A 238.
5. Burdach S, Jurgens H, Peters C et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993; 11: 1482-8.
6. Burgers J M V, Oldenburger J, de Kraker J et al. Ewing's sarcoma of the pelvis: changes over 25 years in treatment and results. Eur J Cancer 1997; 33: 2360-7.
7. Burgert E O J, Nesbit M E, Garnsey L A et al. Multimodal therapy for the management of non-pelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990; 8: 1514-24.
8. Cangir A, Vietti T J, Gehan EA et al. Ewing's sarcoma metastalic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990; 66: 887-93.
9. Castello M A, Dominici C, Clerico A. A pilot study of 5-day continuous infusion of high-dose cisplatin and pulsed etoposide in childhood solid tumors. Am J Pediatr Hematol Oncol 1988; 10: 103-8.
10. Dunst J, Saner R, Burgers J M V et al. Radiotherapie beim Ewing-Sarkom: Aktuelle Ergebnisse der GPO-Studien CESS 81 und CESS 86. Klin P,diatr 1988; 200: 261-6.
11. Elomaa I, Blomqvist C, Saeter G et al. Five-year results of the SSG IX protocol in Ewing's sarcoma. Med Ped Obcol 1996; 27: 225.
12. Fizazi K, Dohollou N, Spielman M et al. Adults with Ewing's sarcoma: a retrospective study of 146 cases. Eur J Cancer 1995; 31A(Suppl.5): 1123.
13. Hayes F A, Thompson E I, Meyer W H et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 1989; 7: 208-13.
14. Hoffmann C, Jabar S, Jurgens H et al. Pelvic Ewing's sarcoma: a retrospective analysis of 241 patients. Joint Meeting EMSOS-AMSTS, 1995; May 8-9, Florence. A: 13.
15. Horowitz M E, Kinsella T J, Wexler L H et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rahabdomyosarcoma. J Clin Oncol 1993; 11: 1911-18.
16. Huvos A. Osteogenic sarcoma. Pathologic assessment of preoperative (neoadjuvant) chemotherapy. Bone tumors. Diagnosis, treatment and prognosis. Philadelphia: WB Saunders Co, 1991; vol 5: 122-8.
17. Jurgens H, Bier V, Dunot D et al. Die GPO Cooperation Ewing-Sarkom Studien CESS 81/86: Bericht nach 6 Jahren. Klin P,diatr 1988; 200: 243-52.
18. Jurgens H, Exner U, Gardner H et al. Multi-disciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European cooperative trial. Cancer 1988; 61: 23-32.
19. Jurgens H, Hoffmann C, Braun-Munzinger G et al. Histological response following preoperative chemotherapy: the CESS experience. Joint Meeting EMSOS-AMSTS, 1995; May 8-9, Florence, A: 63.
20. Jurgens H, Hoffmann C, Kozt R et al. Multi-disciplinary treatment of Ewing's sarcoma: results of the CESS 81 and 86 studies. Eur J Cancer 1995; 31A(Suppl.5): 1197.
21. th Meeting of SIOP, 1996; October 1-5, Vienna. A 0-106.
22. Nesbit M E J, Gehan E A, Burgert E O J et al. Multimodal therapy for management of primary, non-metastatic Ewing's sarcoma of bone: a long-term follow-up of the first Intergruop study. J Clin Oncol 1990; 8: 1664-74.
23. Nilbert M, Saeter G, Elomaa I et al. Ewing's sarcoma treatment in Scandinavia 1984-1990. Ten-year results of the Scandinavian Sarcoma Group Protocol SSG IV. Acta Oncol 1998; 37: 375-8.
24. Nooy M A, Fibbe W, Ouwerkerk J et al. High-dose chemotherapy (HDC) with stemcell rescue for patients with metastatic Ewing's sarcoma. Eur J Cancer 1995; 31A(Suppl.5): 1202.
25. Pape H, Bannach B, Burdach St et al. Ablative chemotherapy and BMT/PSCT in early relapsing or multifocal Ewing's sarcoma. The value of radiotherapy. Eur J Cancer 1995; 31A(Suppl.5): 1123.
26. Pession A, Tienghi A, Rosito P et al. Peripheral blood stem cell transplantation (PBSCT) in high-risk Ewing's sarcoma. Med Ped Oncol 1996; 27: A 0-108.
27. Picci P, Böhling T, Bacci G et al. Chemotherapy induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997; 15: 1553-9.
28. Picci P, Rougraff B T, Bacci G et al. Prognostic significance of histopathologic response to chemotherapy in non-metastatic Ewing's sarcoma of the extremities. J Clin Oncol 1993; 11: 1763-9.
29. Rosen G, Caparros B, Nirenberg A et al. Ewing's sarcoma: Ten years experience with adjuvant chemotherapy. Cancer 1981; 47: 2204-12.
30. Rosito P, Mancini A F, Abate M E et al. Italian cooperative study for treatment of localized Ewing's sarcoma of bone. Med Ped Oncol 1996; 27: 0-196.
31. Saeter G, Elomaa I, Wahlqvist Y et al. Prognostic factors in bone sarcomas. Acta Orthop Scand 1997; 68(Suppl.273): 156-60.
32. Tursz T, Guillot T, Le Chevalier T et al. A pilot study of common combination chemotherapy (PAVI) for neuroectodermal tumors in young adults: Ewing's sarcoma, malignant neuroepithelioma, Askin's tumor. ASCO 1989; 8: A 1231.
33. Valteau-Couanet D, Benhamou E, Oberlin O et al. Consolidation with busulfan and melphalan followed by hematopoietic stem-cell transplantation (SCT) in children with poor prognosis Ewing's sarcoma. Eur J Cancer 1995; 31A(Suppl.5): 1201.
34. Wilkins R M, Pritchard D J, Burgert Jr E O, Unni K K. Ewing's sarcoma of bone. Experiences with 140 patients. Cancer 1986; 58: 2551-5.
35. Wunder J S, Paulian G, Healey J H et al. Chemotherapy induced tumor necrosis as a prognostic indicator in surgically treated Ewing's sarcoma. Joint Meeting EMSOS-AMSTS, 1995; May 8-9, Florence. A:63.